Suppr超能文献

生物活性聚醚醚酮用于犬颈椎前路融合术的体内实验研究

In vivo experimental study of anterior cervical fusion using bioactive polyetheretherketone in a canine model.

作者信息

Shimizu Takayoshi, Fujibayashi Shunsuke, Yamaguchi Seiji, Otsuki Bungo, Okuzu Yaichiro, Matsushita Tomiharu, Kokubo Tadashi, Matsuda Shuichi

机构信息

Department of Orthopedic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Columbia University Medical Center, The Spine Hospital, New York-Presbyterian Healthcare System, New York, NY, United States of America.

出版信息

PLoS One. 2017 Sep 8;12(9):e0184495. doi: 10.1371/journal.pone.0184495. eCollection 2017.

Abstract

BACKGROUND

Polyetheretherketone (PEEK) is a widely accepted biomaterial, especially in the field of spinal surgery. However, PEEK is not able to directly integrate with bone tissue, due to its bioinertness. To overcome this drawback, various studies have described surface coating approaches aimed at increasing the bioactivity of PEEK surfaces. Among those, it has been shown that the recently developed sol-gel TiO2 coating could provide PEEK with the ability to bond with bone tissue in vivo without the use of a bone graft.

OBJECTIVE

This in vivo experimental study using a canine model determined the efficacy of bioactive TiO2-coated PEEK for anterior cervical fusion.

METHODS

Sol-gel-derived TiO2 coating, which involves sandblasting and acid treatment, was used to give PEEK bone-bonding ability. The cervical interbody spacer, which was designed to fit the disc space of a beagle, was fabricated using bioactive TiO2-coated PEEK. Both uncoated PEEK (control) and TiO2-coated PEEK spacers were implanted into the cervical intervertebral space of beagles (n = 5 for each type). After the 3-month survival period, interbody fusion success was evaluated based on μ-CT imaging, histology, and manual palpation analyses.

RESULTS

Manual palpation analyses indicated a 60% (3/5 cases) fusion (no gap between bone and implants) rate for the TiO2-coated PEEK group, indicating clear advantage over the 0% (0/5 cases) fusion rate for the uncoated PEEK group. The bony fusion rate of the TiO2-coated PEEK group was 40% according to μCT imaging; however, it was 0% of for the uncoated PEEK group. Additionally, the bone-implant contact ratio calculated using histomorphometry demonstrated a better contact ratio for the TiO2-coated PEEK group than for the uncoated PEEK group (mean, 32.6% vs 3.2%; p = 0.017).

CONCLUSIONS

The TiO2-coated bioactive PEEK implant demonstrated better fusion rates and bone-bonding ability than did the uncoated PEEK implant in the canine anterior cervical fusion model. Bioactive PEEK, which has bone-bonding ability, could contribute to further improvements in clinical outcomes for spinal interbody fusion.

摘要

背景

聚醚醚酮(PEEK)是一种被广泛认可的生物材料,尤其在脊柱外科领域。然而,由于其生物惰性,PEEK无法直接与骨组织整合。为克服这一缺点,各种研究描述了旨在提高PEEK表面生物活性的表面涂层方法。其中,已表明最近开发的溶胶 - 凝胶TiO₂涂层可使PEEK在不使用骨移植的情况下在体内与骨组织结合。

目的

本体内实验研究使用犬模型确定生物活性TiO₂涂层PEEK用于颈椎前路融合的疗效。

方法

采用涉及喷砂和酸处理的溶胶 - 凝胶衍生TiO₂涂层赋予PEEK骨结合能力。使用生物活性TiO₂涂层PEEK制作设计用于适配比格犬椎间盘间隙的颈椎椎间融合器。将未涂层PEEK(对照)和TiO₂涂层PEEK融合器均植入比格犬的颈椎间隙(每种类型n = 5)。在3个月存活期后,基于μ - CT成像、组织学和手动触诊分析评估椎间融合成功率。

结果

手动触诊分析表明,TiO₂涂层PEEK组的融合率为60%(3/5例)(骨与植入物之间无间隙),明显优于未涂层PEEK组0%(0/5例)的融合率。根据μCT成像,TiO₂涂层PEEK组的骨融合率为40%;然而,未涂层PEEK组为0%。此外,使用组织形态计量学计算的骨 - 植入物接触率显示,TiO₂涂层PEEK组比未涂层PEEK组具有更好的接触率(平均值分别为32.6%和3.2%;p = 0.017)。

结论

在犬颈椎前路融合模型中,TiO₂涂层生物活性PEEK植入物显示出比未涂层PEEK植入物更好的融合率和骨结合能力。具有骨结合能力的生物活性PEEK可能有助于进一步改善脊柱椎间融合的临床结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e872/5590956/4a4669a81f9b/pone.0184495.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验